Search Results - sumit+verma

1 Results Sort By:
Predicting Treatment Response in Patients with Spinal Muscular Atrophy (SMA)
Application Prognostic model predicts treatment response to nusinersen (Spinraza®) in patients with spinal muscular atrophy. Key Benefits A prediction model using baseline CHOP-INTEND, IL-8, fractalkine, and MCP-1 accurately predicts CHOP-INTEND outcomes in children treated with nusinersen The model can also be incorporated into future therapeutic...
Published: 7/30/2024   |   Inventor(s): William Hu, Sumit Verma
Keywords(s): Biomarker, Musculoskeletal, Pediatrics, Rare/Orphan Diseases
Category(s): TechPub Algolia > Diagnostics